Efficacy of Low-Dose BoNT-A Acupoint Injections in Managing Headache, Vertigo, and Allodynia in Vestibular Migraine
The Journal of International Advanced Otology · 2025
DOI: 10.5152/iao.2025.251876 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of International Advanced Otology, 2025. Verfasst von Gökçe Aydemir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery, Pamukkale University Medical School, Denizli, Türkiye. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Acupuncture Points, Migraine Disorders, Vertigo. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: This study examines low-dose botulinum toxin at acupuncture points for its effects on vestibular symptoms, headaches, depression, anxiety, and stress in vestibular migraine patients. METHODS: This prospective study included patients with vestibular migraine per Barany Society criteria. Fifty units of Onabotulinum toxin were injected using a 31-gauge needle at 5 units/0.1 mL, diluted from 100 units with 2 mL of 0.9% sodium chloride. The injections were given at predetermined acupuncture points: Yintang (EX-HN3), Taiyang (EX-HN5), Baihui (GV20), Shuaigu (GB8), Fengchi (GB20), and Tianzhu (BL10). Six-month follow-up assessments included assessments using the Migraine Disability Assessment Scale (MIDAS), Dizziness Handicap Inventory-Screening Form (DHI-S), Vertigo Symptom Scale-Short Form (VSS-SF), Depression Anxiety Stress Scale (DASS-21), and Allodynia Symptom Checklist (ASC-12). RESULTS: Statistically significant improvements were observed in MIDAS, VSS-SF, DHI-S, and DASS-21 scores at both 3 and 6 months (P < .05). CONCLUSION: Application of Onabotulinum toxin A (BoNT-A) to acupuncture points alleviated headache, vestibular symptoms, and anxiety, with benefits persisting for up to 6 months.Cite this article as: Aydemir G, Ardıç FN, Kara CO, Değirmenci E. Efficacy of low-dose BoNT-A acupoint injections in managing headache, vertigo, and allodynia in vestibular migraine. J Int Adv Otol. 2025, 21(4), 1876, doi: 10.5152/iao.2025.251876.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Head and Neck Surgery, Pamukkale University Medical School, Denizli, Türkiye.
- Department of Neurology, Pamukkale University Medical School, Denizli, Türkiye.
ORCID-Profile: Fazıl Necdet Ardıç, Cüneyt Orhan Kara, Eylem Değirmenci
Zitieren
APA
Aydemir, G., Ardıç, F. N., Kara, C. O., & Değirmenci, E. (2025). Efficacy of Low-Dose BoNT-A Acupoint Injections in Managing Headache, Vertigo, and Allodynia in Vestibular Migraine. The Journal of International Advanced Otology. https://doi.org/10.5152/iao.2025.251876
Vancouver
Aydemir G, Ardıç FN, Kara CO, Değirmenci E. Efficacy of Low-Dose BoNT-A Acupoint Injections in Managing Headache, Vertigo, and Allodynia in Vestibular Migraine. The Journal of International Advanced Otology. 2025. doi:10.5152/iao.2025.251876
BibTeX
@article{Aydemir2025,
author = {Aydemir, Gökçe and Ardıç, Fazıl Necdet and Kara, Cüneyt Orhan and Değirmenci, Eylem},
title = {Efficacy of Low-Dose BoNT-A Acupoint Injections in Managing Headache, Vertigo, and Allodynia in Vestibular Migraine},
journal = {The Journal of International Advanced Otology},
year = {2025},
doi = {10.5152/iao.2025.251876}
}
EUVIMED